drugset / Trial / NCT03070613

Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery

NCT03070613 ↗

Phase 0 Unknown 50 enrolled University of Oxford
NaSingle-groupOpen-labelDiagnostic

Summary

This is a feasibility study investigating the use of a fluorescently conjugated lectin to identify colorectal dysplasia and cancer during colonoscopy and surgery.

Timeline

Start
2017-04-23
Primary completion
2018-03-01
Completion
2018-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein conjugated wisteria floribunda Diagnostic / imaging agent — Topical